T1	Participants 218 251	childhood lymphoblastic leukaemia
T2	Participants 785 850	All patients received 6-thioguanine during intensification course
T3	Participants 521 638	Consecutive children with lymphoblastic leukaemia diagnosed in the UK and Ireland between April, 1997, and June, 2002
T4	Participants 1653 1710	95 patients developed veno-occlusive disease of the liver
T5	Participants 1722 1811	82 were randomly assigned 6-thioguanine, representing 11% of all 6-thioguanine recipients
T6	Participants 1843 1924	5% of 6-thioguanine recipients have evidence of non-cirrhotic portal hypertension
